BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17726808)

  • 1. Effect of hormone therapy on lipid profile in menopausal women.
    Saranyaratana W; Sakondhavat C; Silaruks S; Soontrapa S; Kaewrudee S
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S37-41. PubMed ID: 17726808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipids and lipoproteins in relation to endogenous and exogenous female sex steroids and age. The Women's Health in the Lund Area (WHILA) study.
    Nerbrand C; Lidfeldt J; Nyberg P; Scherstén B; Samsioe G
    Maturitas; 2004 Jun; 48(2):161-9. PubMed ID: 15172091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance.
    Erenus M; Karakoç B; Gürler A
    Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J
    Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
    Balci H; Altunyurt S; Acar B; Fadiloglu M; Kirkali G; Onvural B
    Maturitas; 2005 Apr; 50(4):289-93. PubMed ID: 15780528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors of urinary incontinence in Khon Kaen menopausal women.
    Sakondhavat C; Choosuwan C; Kaewrudee S; Soontrapa S; Louanka K
    J Med Assoc Thai; 2007 Dec; 90(12):2553-8. PubMed ID: 18386703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Raja yoga meditation on the lipid profile of post-menopausal women.
    Vyas R; Raval KV; Dikshit N
    Indian J Physiol Pharmacol; 2008; 52(4):420-4. PubMed ID: 19585761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy.
    Petri Nahas E; Nahás Neto J; De Luca L; Traiman P; Pontes A; Dalben I
    Maturitas; 2004 Aug; 48(4):372-80. PubMed ID: 15283929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in lipid metabolism in postmenopausal Japanese women using hormone therapy evaluated by capillary isotachophoresis: a pilot study.
    Inoue Y; Zhang B; Sadamori R; Shirota K; Saku K; Kawarabayashi T
    Menopause; 2008; 15(1):157-63. PubMed ID: 17603392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between serum cholesterol and bone mineral density.
    Makovey J; Chen JS; Hayward C; Williams FM; Sambrook PN
    Bone; 2009 Feb; 44(2):208-13. PubMed ID: 18983946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid profile of women with premature ovarian failure.
    Knauff EA; Westerveld HE; Goverde AJ; Eijkemans MJ; Valkenburg O; van Santbrink EJ; Fauser BC; van der Schouw YT
    Menopause; 2008; 15(5):919-23. PubMed ID: 18551082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of estrogen therapy on microalbuminuria in healthy post-menopausal women.
    Machado RB; Careta MF; Balducci GP; Araújo TS; Bernardes CR
    Gynecol Endocrinol; 2008 Dec; 24(12):681-5. PubMed ID: 19172536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, case-control study on the lipid profile and the cardiovascular risk of menopausal women on oestrogen plus progestogen therapy in a northern Italy province.
    Patrelli TS; Gizzo S; Franchi L; Berretta R; Pedrazzi G; Volpi L; Lukanovic A; Zanni GC; Modena AB
    Arch Gynecol Obstet; 2013 Jul; 288(1):91-7. PubMed ID: 23287887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial work environment and lifestyle as related to lipid profiles in perimenopausal women.
    Evolahti A; Hultcrantz M; Collins A
    Climacteric; 2009 Apr; 12(2):131-45. PubMed ID: 19085562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety of hormone replacement therapy in menopause and its favorable effect on the lipid spectrum].
    Murín J; Borovský M; Payer J; Killinger Z; Stecová L
    Vnitr Lek; 1995 Oct; 41(10):672-6. PubMed ID: 8578697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge-attitude-practice of sexual intercourse of post-menopausal women using hormone replacement therapy.
    Somboonporn W; Seejorn K; Kleebkaow P; Junthathamrongwat N; Ratanasiri T
    J Med Assoc Thai; 2002 Feb; 85(2):167-71. PubMed ID: 12081115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hormone replacement therapy on hemostatic variables in post-menopausal women.
    Al-Farra HM; Al-Fahoum SK; Tabbaa MA
    Saudi Med J; 2005 Dec; 26(12):1930-5. PubMed ID: 16380775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of estrogen replacement and exercise protects against HDL oxidation in post-menopausal women.
    Lawler JM; Hu Z; Green JS; Crouse SF; Grandjean PW; Bounds RG
    Int J Sports Med; 2002 Oct; 23(7):477-83. PubMed ID: 12402178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two forms of continuous combined hormone replacement therapy with respect to metabolic effects.
    Tugrul S; Yildirim G; Pekin O; Uslu H; Kutlu T; Eren S
    Arch Gynecol Obstet; 2007 May; 275(5):335-9. PubMed ID: 17051405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.